ROCKWELL MEDICAL, INC. Public Float
ROCKWELL MEDICAL, INC. (RMTI) had Public Float of $28.69 million as of 2025-06-30, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-26
- 2025-06-30: Entity Public Float $28.69M.
- 2024-06-30: Entity Public Float $53.98M.
- 2023-06-30: Entity Public Float $91.05M.
- 2022-06-30: Entity Public Float $11.10M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $28.69M 10-K · filed 2026-03-26 |
| 2024-06-30 | $53.98M 10-K · filed 2025-03-20 |
| 2023-06-30 | $91.05M 10-K · filed 2024-03-21 |
| 2022-06-30 | $11.10M 10-K · filed 2023-03-30 |
| 2021-06-30 | $29.01M 10-K · filed 2022-04-08 |
| 2020-06-30 | $111.97M 10-K · filed 2021-03-31 |
| 2019-06-30 | $152.51M 10-K · filed 2020-03-17 |
| 2018-06-30 | $254.46M 10-K · filed 2019-03-18 |
| 2017-06-30 | $330.27M 10-K · filed 2018-03-15 |
| 2016-06-30 | $318.84M 10-K · filed 2017-03-15 |
| 2015-06-30 | $761.64M 10-K · filed 2016-02-29 |
| 2014-06-30 | $457.07M 10-K · filed 2015-03-03 |
| 2013-06-30 | $135.65M 10-K · filed 2014-03-07 |
| 2012-06-30 | $140.02M 10-K · filed 2013-03-18 |
| 2011-06-30 | $191.63M 10-K · filed 2012-03-05 |
| 2010-06-30 | $76.56M 10-Q · filed 2011-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |